Skip to main content

Month: August 2025

MiniLuxe Announces Best of Boston Award for Manicure and Pedicure Services

MiniLuxe wins the annual Boston Magazine, Best of Boston Award for Best Mani and Pedi Boston, MA, Aug. 06, 2025 (GLOBE NEWSWIRE) — MiniLuxe, a leader in clean beauty and self-care services, proudly announces receiving Best Manicure and Pedicure Services granted by Boston Magazine’s Best of Boston 2025. Meticulously researched by the magazine’s writers and editors who spend months testing and debating, Boston Magazine’s list of winners represents “Boston’s must-visit list this year.” MiniLuxe has won the award multiple times since its founding. “It is wonderful to gain local recognition from Boston Magazine. As MiniLuxe started in the greater Boston area, this award is very meaningful to us and is equally a testament to the quality and dedication of our nail designers and waxing specialists,” said Tony Tjan, CEO of MiniLuxe. The...

Continue reading

Vishay Intertechnology Reports Second Quarter 2025 Results

MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc., (NYSE: VSH), one of the world’s largest manufacturers of discrete semiconductors and passive electronic components, today announced results for the fiscal second quarter ended June 28, 2025. Highlights2Q 2025 revenues of $762.3 million Gross margin was 19.5% and included the negative impact of approximately 160 basis points related to the addition of Newport 2Q 2025 EPS of $0.01 2Q 2025 Adjusted loss per share of $(0.07) 2Q 2025 book-to-bill of 1.02 with book-to-bill of 0.98 for semiconductors and 1.06 for passive components Backlog at quarter end was 4.6 months“The promising signals we saw emerging at the beginning of the year contributed to a 7% sequential increase in revenue for the second quarter. We delivered growth for semis and passives,...

Continue reading

Vertex Announces Second Quarter 2025 Financial Results

KING OF PRUSSIA, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its second quarter ended June 30, 2025. “This quarter’s results were in line with expectations, with double-digit revenue growth and healthy profitability and cash flow,” said David DeStefano, Vertex’s President, Chief Executive Officer and Chairperson of the Board. “We continue to be optimistic about the future for Vertex. As indirect taxes continue to grow in complexity, our customers need our solutions more than ever. In addition, ERP cloud conversions and the proliferation of e-invoicing mandates globally are expected to be durable long-term drivers of growth.” Second Quarter 2025 Financial ResultsTotal revenues of $184.6...

Continue reading

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

Conference call today at 9:00 am ET2Q 2025 revenues of $76.5M, +6% v. 2Q 2024 YTD 2025 revenues of $154.9M, +12% v. YTD 2024 Advanced pipeline:Submitted sBLA for Afrezza® in pediatric population MNKD-101: NTM global Phase 3 trial (ICoN-1) enrollment ahead of schedule MNKD-201: Plan to initiate Phase 2 clinical trial for IPF by YE 2025DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) today reported financial results for the second quarter 2025 and provided a business update. “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. “In our orphan lung pipeline,...

Continue reading

Avista Corp. Reports Financial Results for the Second Quarter of 2025, Confirms 2025 Earnings Guidance with Strong Utility Offsetting Investment Losses

SPOKANE, Wash., Aug. 06, 2025 (GLOBE NEWSWIRE) — Avista Corp. (NYSE: AVA) today announced financial results for the second quarter of 2025. Net income and earnings per diluted share for the second quarter and year-to-date 2025 compared to the same periods in 2024 are presented in the table below (dollars in millions, except per-share data):    Second Quarter     Year-to-Date      2025     2024     2025     2024  Net Income (Loss) by:                        Reportable Segments                        Avista Utilities   $ 23     $ 24     $ 101     $ 91  AEL&P     1       1       4       5  Other non-reportable segment loss     (10 )     (2 )     (12 )     (2 )Total net income   $ 14     $ 23     $ 93     $ 94  Earnings (Loss) per Diluted Share:                        Reportable Segments                        Avista...

Continue reading

Gilat Reports Second Quarter 2025 Results

Revenues Increased by 37%; GAAP Operating Income of $5.7 Million; Adjusted EBITDA of $11.8 Million Raises Midpoint of 2025 Revenue and EBITDA Guidance PETAH TIKVA, Israel, Aug. 06, 2025 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today reported its results for the second quarter, ended June 30, 2025. Second Quarter 2025 Financial HighlightsRevenues of $105 million, up 37% compared with $76.6 million in Q2 2024; GAAP operating income of $5.7 million, compared with GAAP operating income of $2.8 million in Q2 2024; Non-GAAP operating income of $9.3 million, compared with $7.3 million in Q2 2024; GAAP net income of $9.8 million, or $0.17 per diluted share, compared with GAAP net income of $1.3 million, or $0.02 per diluted...

Continue reading

30.1% Gross Margin and Lower Operating Expenses Enable Orion to Generate Positive Adjusted EBITDA on Q1’26 Revenue of $19.6M; Reiterates FY 2026 Outlook

MANITOWOC, Wis., Aug. 06, 2025 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today reported results for its fiscal 2026 first quarter (Q1’26) ended June 30, 2025, retaining its three segment reporting structure. Orion maintained its FY 2026 revenue growth outlook of 5% to approximately $84M, which should position it to approach or achieve positive FY 2026 adjusted EBITDA. Orion will hold an investor call today at 10:00 a.m. ET – details below.  Q1 Financial Summary   Prior Three Quarters$ in millions except per share figures Q1’26 Q1’25 Change   Q4’25 Q3’25 Q2’25LED Lighting Revenue $12.9 $12.8 +1%   $10.9 $13.2 $10.8EV Charging Revenue $2.7 $3.8 -30%   $5.8 $2.4 $4.7Maintenance...

Continue reading

Fortrea Reports Second Quarter 2025 Results

For the three months ended June 30, 2025, from continuing operations:Revenues of $710.3 million GAAP net loss of $(374.9) million, inclusive of a non-cash goodwill impairment charge Adjusted EBITDA of $54.9 million GAAP and adjusted net (loss) income per diluted share of $(4.14) and $0.19, respectively Book-to-bill ratio of 0.79x, resulting in 1.10x book-to-bill for the trailing 12 months Cost saving initiatives remain on track Raising 2025 revenue guidance to a range of $2,600 million to $2,700 million; affirming 2025 adjusted EBITDA guidanceDURHAM, N.C., Aug. 06, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today reported financial results for the second quarter ended June 30, 2025. “As Fortrea marked two years of independence at the end of June, the...

Continue reading

Magnera Reports Third Quarter Results – Provides Updated Outlook

Third Quarter HighlightsGAAP: Net sales of $839 million, Operating income of $13 million Non-GAAP: Adjusted EBITDA of $91 million Confirming post-merger adjusted free cash flow and Adjusted EBITDA rangeCHARLOTTE, N.C., Aug. 06, 2025 (GLOBE NEWSWIRE) — Magnera (NYSE: MAGN), a global leader in specialty materials for the consumer products and personal care markets, today reported financial results for its fiscal 2025 third quarter ended June 28, 2025. Curt Begle, Magnera’s CEO, commented: “Reflecting on the third quarter, I am pleased with our progress and what we have achieved in these challenging market conditions. We are confirming our original free cash flow guidance as well as the range of adjusted EBITDA communicated in our second quarter earnings call. Looking ahead, we are energized by the value creation opportunities...

Continue reading

Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent

Designed to expand PSMA PET imaging access for patients by increasing batch size by ~50% and enhancing supply resiliencePDUFA date set for March 6, 2026 BEDFORD, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that the Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for a new formulation of its F 18 PSMA imaging agent filed by its affiliate, Aphelion. The FDA has set an action date goal of March 6, 2026 under the Prescription Drug User Fee Act (PDUFA). This NDA acceptance builds on the success of Lantheus’ market-leading PSMA PET imaging agent, PYLARIFY, which has demonstrated high diagnostic...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.